Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (964)	1/24/1999 10:44:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 2539

Monsanto gets new federal OK on milk hormone ST. LOUIS -- Reaffirming that a Monsanto Co. (MTC) drug is safe, the nation's top health officer has rejected appeals from critics to pull the genetically engineered product from the market. Donna E. Shalala, secretary of health and human services, said the critics of BST -- the drug that increases cows' milk production -- have raised "no new scientific concerns" about the drug's safety. That means the Food and Drug Administration, which reports to her, "does not intend to remove the product from the market," Shalala said in a letter sent Thursday to Vermont Sens. Patrick J. Leahy and James M. Jeffords. After a slow start, the drug, sold under the brand name Posilac, has recorded higher sales each year. Last year, it produced an estimated $200 million in revenue. Canada's top health agency, HealthCanada, rejected BST last week. (St. Louis Post-Dispatch)